Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2010-12-17
pubmed:abstractText
Information about the cost-effectiveness of aripiprazole relative to other atypical antipsychotics in the treatment of patients with schizophrenia is limited. This information is needed to better inform drug formulary managers and population-based health care decision makers. The objective of this study was to compare the cost-effectiveness of olanzapine to aripiprazole in the treatment of schizophrenia from the perspective of public payers in the United States.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1473-4877
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
115-22
pubmed:meshHeading
pubmed-meshheading:21110749-Adolescent, pubmed-meshheading:21110749-Adult, pubmed-meshheading:21110749-Antipsychotic Agents, pubmed-meshheading:21110749-Benzodiazepines, pubmed-meshheading:21110749-Cost-Benefit Analysis, pubmed-meshheading:21110749-Double-Blind Method, pubmed-meshheading:21110749-Female, pubmed-meshheading:21110749-Humans, pubmed-meshheading:21110749-Male, pubmed-meshheading:21110749-Middle Aged, pubmed-meshheading:21110749-Multicenter Studies as Topic, pubmed-meshheading:21110749-Piperazines, pubmed-meshheading:21110749-Quinolones, pubmed-meshheading:21110749-Randomized Controlled Trials as Topic, pubmed-meshheading:21110749-Retrospective Studies, pubmed-meshheading:21110749-Schizophrenia, pubmed-meshheading:21110749-Treatment Outcome, pubmed-meshheading:21110749-United States, pubmed-meshheading:21110749-Young Adult
pubmed:year
2011
pubmed:articleTitle
Cost-effectiveness of olanzapine vs. aripiprazole in the treatment of schizophrenia.
pubmed:affiliation
Eli Lilly and Company, Lilly Corporate Center, DC 4133, Indianapolis, IN 46285, USA. haya@lilly.com
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't, Evaluation Studies